The partnership will develop and commercialise novel custom antibodies for cancer research
News
UK scientists plead with PM for charity partnership fund
A £310 million cut in UK medical research investment is predicted this year
Novartis banks EC approval for Enerzair Breezhaler
The product includes the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU
NHS launches ‘Your COVID Recovery’ service
The service will help COVID-19 survivors who are still experiencing problems with breathing, mental health or other complications.
Immune Regulation teams with DynPort on COVID-19 drug
The companies will jointly evaluate the potential of ILR201104 to treat COVID-19 related Acute Respiratory Distress Syndrome (ARDS)
King’s researchers win £1m grant for COVID-19 research
The grant, from the Huo Family Foundation, will support research into better understanding the immune response to SARS-CoV-2 infection
UK study to research long-term health impact of COVID-19
The PHOSP-COVID study will support the development of new strategies for clinical and rehabilitation care
Communiqué 2020 – winners announced!
The competition’s first ever virtual awards ceremony racked up over 1,400 live views
King’s receives £1m grant for mental health centre
The Pears Maudsley Centre for Children and Young People will bring together the world’s leading experts in clinical care and research
Partnership gets £4.4m gov grant for better liver diagnostics
The partnership includes Perspectum, the Universities of Manchester and Birmingham, Roche Diagnostics, GE Medical Systems and Jiva.Ai
FDA approves ViiV’s novel HIV treatment Rukobia
60% of heavily treatment-experienced patients achieved undetectable viral load after taking the drug
Sanofi, Regeneron pull plug on Kevzara COVID-19 trial
The drug failed to show any significant benefit in patient requiring mechanical ventilation
Communiqué winners unveiled today in first ever digital ceremony
Watch the show from 4pm at pmlive.com/cxhealth
EUSA Pharma bags US approval for COVID-19 trial
Siltuximab is a monoclonal antibody that directly neutralises interleukin (IL)-6, an inflammatory cytokine
NIHR’s CRN supports record number of commercial studies
The NIHR CRN supported 1,580 commercial studies in 2019/20
